即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 210826-40-7 | 货号 | BCP15729 |
中文名 | MCC-950 | ||
英文名 | MCC-950 | ||
中文别名 | |||
英文别名 | MCC 950;MCC950;CP-456773;CP 456773;CP456773; CRID-3; CRID3; CRID 3; | ||
SMILES | O=S(C1=CC(C(C)(O)C)=CO1)(NC(NC2=C3CCCC3=CC4=C2CCC4)=O)=O | ||
化学名称 | |||
分子式 | C20H24N2O5S | 分子量 | 404.48 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | MCC950 , also known as CP-456773 and CRID3, is a potent and selective cytokine release inhibitor and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases. CP-456773 inhibits interleukin 1β (IL-1β) secretion and caspase 1 processing. MCC950 blocked canonical and noncanonical NLRP3 activation at nanomolar concentrations. MCC950 specifically inhibited activation of NLRP3 but not the AIM2, NLRC4 or NLRP1 inflammasomes. MCC950 reduced interleukin-1β (IL-1β) production in vivo and attenuated the severity of experimental autoimmune encephalomyelitis (EAE), a disease model of multiple sclerosis. MCC950 is a potential therapeutic for NLRP3-associated syndromes, including autoinflammatory and autoimmune diseases, and a tool for further study of the NLRP3 inflammasome in human health and disease. |
Tags:MCC-950 供应商,MCC-950 购买,MCC-950 生产,MCC-950 批量,MCC-950 供应,MCC-950 订购,MCC-950 采购